Table 1 Baseline characteristics of the study patients
No. of subjects | 98 |
|---|---|
Male gender, n (%) | 58 (59.2) |
Age, years | 68.9 ± 11.7 |
BMI, kg/m2 | 22.4 ± 3.6 |
Chronic hemodialysis, n (%) | 9 (9.2) |
Co-morbidities | |
Hypertension, n (%) | 62 (63.3) |
Diabetes, n (%) | 25 (25.5) |
Collagen vascular diseases, n (%) | 5 (5.1) |
Malignant disorders, n (%) | 20 (20.4) |
Smoking status | |
Never (%) | 48 (49.0) |
Former (%) | 41 (41.8) |
Current (%) | 9 (9.2) |
Laboratory data | |
White blood cell count, ×103/μL | 6.5 ± 3.4 |
Eosinophil count, /μL | 188 ± 154 |
Hemoglobin, g/dL | 12.6 ± 2.0 |
Platelet count, ×104/μL | 19.8 ± 5.9 |
Total protein, g/dL | 6.8 ± 0.6 |
Albumin, g/dL | 3.8 ± 0.5 |
Creatininea, mg/dL | 1.0 ± 0.4 |
eGFRa, mL/min/1.73 m2 | 59.2 ± 20.0 |
C-reactive protein, median (IQR) mg/dL | 0.14 (0.04–1.65) |
Amylase, U/L | 90.9 ± 42.7 |